Delivery Order SPE2DB22D2206-SPE2DB25FJA08
- Not listed
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections, valued at $1,088.36. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a contract value of $4,568.72. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,523.07 on August 8, 2025, for Mounjaro 7.5 mg/0.5 ml pen injections. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under the agency's pharmaceutical procurement framework. The order is scheduled for completion by August 11, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued...
- The Defense Logistics Agency awarded a $20,113.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections (0.5 ml). The contract is set to be completed by July 31, 2025, with performance occurring at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $20,300.82. This is a firm fixed-price delivery order with no set-aside designation, classified as a competitive award. The order is scheduled for ultimate completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,028.73 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen injections on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $1,571.57. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to support federal medical procurement needs. The contract is set to complete by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,758.57 firm fixed-price delivery order on August 14, 2025, for Mounjaro 2.5 mg/0.5 mL pen injections, with an ultimate completion date of August 15, 2025. The contract, issued without set-aside designation, represents a competitively awarded procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA08Delivery Order
The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government through the Defense Logistics Agency's medical supply chain. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Mounjaro, a diabetes medication, exemplifies the specialized pharmaceutical products that AmerisourceBergen delivers through this vehicle to support the Defense Health Agency and other government healthcare systems. The company's continued selection for such awards reflects its demonstrated capability to meet federal procurement requirements through competitive bidding and reliable delivery of critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/22/25 |